New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
The prospects of using new drug of statine class – pitavastatine – in the prophylaxis and treatment of cardiovascular diseases have been considered in this review. The data of international іnvestigations on the comparative effi cacy of pitavastatine have been given; its pleiotropic effects, high...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2014-04-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/24831/22316 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849253866922573824 |
|---|---|
| author | V. V. Syvolap M. P. Gerasko |
| author_facet | V. V. Syvolap M. P. Gerasko |
| author_sort | V. V. Syvolap |
| collection | DOAJ |
| description | The prospects of using new drug of statine class – pitavastatine – in the prophylaxis and treatment of cardiovascular diseases have
been considered in this review. The data of international іnvestigations on the comparative effi cacy of pitavastatine have been given; its pleiotropic effects, high profi le safety and tolerance, the decrease in the risk of drugs’ interaction have been shown. |
| format | Article |
| id | doaj-art-5a0f83a1fa954730ab8b2b2f90c797bb |
| institution | Kabale University |
| issn | 2306-8094 2409-2932 |
| language | English |
| publishDate | 2014-04-01 |
| publisher | Zaporizhzhia State Medical and Pharmaceutical University |
| record_format | Article |
| series | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| spelling | doaj-art-5a0f83a1fa954730ab8b2b2f90c797bb2025-08-20T03:56:12ZengZaporizhzhia State Medical and Pharmaceutical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322014-04-011505410.14739/2409-2932.2014.1.24831New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factorsV. V. Syvolap M. P. GeraskoThe prospects of using new drug of statine class – pitavastatine – in the prophylaxis and treatment of cardiovascular diseases have been considered in this review. The data of international іnvestigations on the comparative effi cacy of pitavastatine have been given; its pleiotropic effects, high profi le safety and tolerance, the decrease in the risk of drugs’ interaction have been shown.http://pharmed.zsmu.edu.ua/article/view/24831/22316cardiovascular diseasesdyslipidemiatreatment; pitavastatin |
| spellingShingle | V. V. Syvolap M. P. Gerasko New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki cardiovascular diseases dyslipidemia treatment; pitavastatin |
| title | New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors |
| title_full | New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors |
| title_fullStr | New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors |
| title_full_unstemmed | New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors |
| title_short | New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors |
| title_sort | new features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors |
| topic | cardiovascular diseases dyslipidemia treatment; pitavastatin |
| url | http://pharmed.zsmu.edu.ua/article/view/24831/22316 |
| work_keys_str_mv | AT vvsyvolap newfeaturescorrectionofthedyslipidemiainpatientswithdiabetesmellitusandmetaboliccardiovascularriskfactors AT mpgerasko newfeaturescorrectionofthedyslipidemiainpatientswithdiabetesmellitusandmetaboliccardiovascularriskfactors |